These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15589636)

  • 1. Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME).
    Claude J; Schindler C; Kuster GM; Schwenkglenks M; Szucs T; Buser P; Osswald S; Kaiser C; Grädel C; Estlinbaum W; Rickenbacher P; Pfisterer M;
    Eur Heart J; 2004 Dec; 25(24):2195-203. PubMed ID: 15589636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME).
    Pfisterer M;
    Circulation; 2004 Sep; 110(10):1213-8. PubMed ID: 15337691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients.
    Weintraub WS; Boden WE; Zhang Z; Kolm P; Zhang Z; Spertus JA; Hartigan P; Veledar E; Jurkovitz C; Bowen J; Maron DJ; O'Rourke R; Dada M; Teo KK; Goeree R; Barnett PG;
    Circ Cardiovasc Qual Outcomes; 2008 Sep; 1(1):12-20. PubMed ID: 20031783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients.
    Stroupe KT; Morrison DA; Hlatky MA; Barnett PG; Cao L; Lyttle C; Hynes DM; Henderson WG;
    Circulation; 2006 Sep; 114(12):1251-7. PubMed ID: 16966588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative cost comparison of treatments for coronary artery disease: the First Year Follow-Up of MASS II Study.
    Favarato D; Hueb W; Gersh BJ; Soares PR; Cesar LA; da Luz PL; Oliveira SA; Ramires JA;
    Circulation; 2003 Sep; 108 Suppl 1():II21-3. PubMed ID: 12970202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.
    Hlatky MA; Boothroyd DB; Melsop KA; Brooks MM; Mark DB; Pitt B; Reeder GS; Rogers WJ; Ryan TJ; Whitlow PL; Wiens RD
    Circulation; 2004 Oct; 110(14):1960-6. PubMed ID: 15451795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.
    Zhang Z; Mahoney EM; Spertus JA; Booth J; Nugara F; Kolm P; Stables RH; Weintraub WS
    Am Heart J; 2006 Dec; 152(6):1153-60. PubMed ID: 17161069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
    Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Economic evaluation of different treatment strategies in patients with stable angina pectoris or asymptomatic myocardial ischemia on basis of results from the Asymptomatic-Cardiac-Ischemia Pilot study (ACIP)].
    Szucs TD; Schwenkglenks M; Rutishauser W
    Med Klin (Munich); 2000 Jan; 95(1):1-13. PubMed ID: 10668338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
    Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
    J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does off-pump or minimally invasive coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with percutaneous coronary intervention? A meta-analysis of randomized trials.
    Bainbridge D; Cheng D; Martin J; Novick R;
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):623-31. PubMed ID: 17320555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. eComment: Costs of percutaneous coronary intervention versus coronary artery bypass surgery.
    Almeida RM
    Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):672. PubMed ID: 19443497
    [No Abstract]   [Full Text] [Related]  

  • 13. Residual high-grade angina after enhanced external counterpulsation therapy.
    McCullough PA; Henry TD; Kennard ED; Kelsey SF; Michaels AD;
    Cardiovasc Revasc Med; 2007; 8(3):161-5. PubMed ID: 17765644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of alternative strategies to treat patients with diabetes mellitus and coronary artery disease.
    Hlatky MA; Melsop KA; Boothroyd DB;
    Am J Cardiol; 2006 Jun; 97(12A):59G-65G. PubMed ID: 16813739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial.
    Zhang Z; Spertus JA; Mahoney EM; Booth J; Nugara F; Stables RH; Weintraub WS
    Am Heart J; 2005 Jul; 150(1):175-81. PubMed ID: 16084166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
    Lenzen MJ; Boersma E; Bertrand ME; Maier W; Moris C; Piscione F; Sechtem U; Stahle E; Widimsky P; de Jaegere P; Scholte op Reimer WJ; Mercado N; Wijns W;
    Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks and benefits of optimised medical and revascularisation therapy in elderly patients with angina--on-treatment analysis of the TIME trial.
    Kaiser C; Kuster GM; Erne P; Amann W; Naegeli B; Osswald S; Buser P; Schläpfer H; Brett W; Zerkowski HR; Schindler C; Pfisterer M;
    Eur Heart J; 2004 Jun; 25(12):1036-42. PubMed ID: 15191774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative economic analyses of minimally invasive direct coronary artery bypass surgery.
    Gray DT; Veenstra DL
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):618-24. PubMed ID: 12658204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cost-effectiveness analysis of an invasive therapeutic approach to coronary disease].
    Urban P
    Schweiz Med Wochenschr; 1996 Sep; 126(39):1661-4. PubMed ID: 8927970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced external counterpulsation--a therapeutic option for patients with chronic cardiovascular problems.
    Linnemeier G
    J Cardiovasc Manag; 2002; 13(6):20-5. PubMed ID: 12500419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.